348 related articles for article (PubMed ID: 2087668)
21. [Blast crisis accompanied by severe DIC of Ph negative chronic myeloid leukemia showing t(9;16) and positive M-BCR/ABL rearrangement].
Fujiwara H; Takahashi N; Tada J; Higuchi T; Harada H; Mori H; Niikura H; Omine M; Fujita K
Rinsho Ketsueki; 1997 Aug; 38(8):663-68. PubMed ID: 9311272
[TBL] [Abstract][Full Text] [Related]
22. Generation of the BCR/ABL fusion gene in a Philadelphia chromosome-negative chronic myeloid leukaemia: insertion of 5.6 Mb of 9q34 into the BCR region of chromosome 22.
Valle L; Fernández V; Pérez-Pons C; Sánchez FG; Benítez J; Urioste M
Hematol Oncol; 2006 Jun; 24(2):86-8. PubMed ID: 16598834
[TBL] [Abstract][Full Text] [Related]
23. Fluorescence in situ hybridization characterization of different cryptic BCR-ABL rearrangements in chronic myeloid leukemia.
Haigh S; Cuthbert G
Cancer Genet Cytogenet; 2004 Dec; 155(2):132-7. PubMed ID: 15571798
[TBL] [Abstract][Full Text] [Related]
24. [Molecular biology of chronic myeloid leukemia].
Hellmann A
Acta Haematol Pol; 1992; 23(2 Suppl 1):13-7. PubMed ID: 1488867
[TBL] [Abstract][Full Text] [Related]
25. [The Philadelphia chromosome 30 years later].
Lisker R
Rev Invest Clin; 1992; 44(1):123-30. PubMed ID: 1523343
[TBL] [Abstract][Full Text] [Related]
26. [Cytogenetic and molecular analysis of 1193 cases with chronic myeloid leukemia].
Jiang DZ; Chen ZM; Lou JY; Wang YG; Liang Y; Jin J
Zhonghua Xue Ye Xue Za Zhi; 2007 Jan; 28(1):1-5. PubMed ID: 17649716
[TBL] [Abstract][Full Text] [Related]
27. [Molecular study of Ph1 chromosome negative chronic myelocytic leukemia].
Chen S
Zhonghua Yi Xue Za Zhi; 1991 Aug; 71(8):425-7, 30. PubMed ID: 1660759
[TBL] [Abstract][Full Text] [Related]
28. The bcr gene is joined to c-abl in Ph1 chromosome negative chronic myelogenous leukemia.
Dreazen O; Klisak I; Rassool F; Goldman JM; Sparkes RS; Gale RP
Oncogene Res; 1988; 2(2):167-75. PubMed ID: 3217110
[TBL] [Abstract][Full Text] [Related]
29. Absence in Ph-negative, M-BCR rearrangement-positive chronic myelogenous leukemia of linkage between 5' ABL and 3' M-BCR sequences in Philadelphia translocation.
Nishigaki H; Misawa S; Inazawa J; Abe T
Leukemia; 1992 May; 6(5):385-92. PubMed ID: 1593904
[TBL] [Abstract][Full Text] [Related]
30. [Chronic myeloid leukemia without Philadelphia chromosome (Ph-negative CML)].
Haus O
Acta Haematol Pol; 1993; 24(3):221-5. PubMed ID: 8249537
[TBL] [Abstract][Full Text] [Related]
31. [Clonal evolution of abnormal Philadelphia chromosome-negative cells after imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia].
Jiang Q; Chen SS; Jiang B; Jiang H; Lu Y; Qiu JY; Lu DP
Zhonghua Xue Ye Xue Za Zhi; 2005 Jan; 26(1):23-6. PubMed ID: 15946504
[TBL] [Abstract][Full Text] [Related]
32. Molecular status of individual CFU-GM colonies derived from chemotherapy-mobilised peripheral blood stem cells in chronic myeloid leukaemia.
Broughton CM; Sherrington P; Pender NT; Clark RE
Genes Chromosomes Cancer; 1997 Apr; 18(4):292-8. PubMed ID: 9087569
[TBL] [Abstract][Full Text] [Related]
33. Amplification of BCR-ABL and t(3;21) in a patient with blast crisis of chronic myelogenous leukemia.
Phan CL; Megat Baharuddin PJ; Chin LP; Zakaria Z; Yegappan S; Sathar J; Tan SM; Purushothaman V; Chang KM
Cancer Genet Cytogenet; 2008 Jan; 180(1):60-4. PubMed ID: 18068536
[TBL] [Abstract][Full Text] [Related]
34. Philadelphia chromosome-negative, bcr/abl-positive chronic myelogenous leukemia.
Inokuchi K; Dan K
J Nippon Med Sch; 2001 Aug; 68(4):292-3. PubMed ID: 11505275
[No Abstract] [Full Text] [Related]
35. Detection of minimal residual disease using clonospecific primers for CDRIII in patients with acute B lymphocytic leukemia with or without Philadelphia chromosome: possibility of clinical application as a tool for improving prognosis.
Maeda Y; Horiuchi F; Morita S; Matsuda M; Shirakawa C; Masaki H; Koyama A; Hamazaki H; Fujimoto T; Irimajiri K
Exp Hematol; 1994 Aug; 22(9):881-7. PubMed ID: 8062887
[TBL] [Abstract][Full Text] [Related]
36. Extramedullary BCR-ABL1-negative myeloid leukemia in a patient with chronic myeloid leukemia and synchronous cytogenetic abnormalities in Philadelphia-positive and -negative clones during imatinib therapy.
Quintás-Cardama A; Kantarjian H; Abruzzo LV; Cortes J
Leukemia; 2007 Nov; 21(11):2394-6. PubMed ID: 17690707
[No Abstract] [Full Text] [Related]
37. Clinical and biological aspects of Philadelphia-negative/BCR-negative chronic myeloid leukemia.
Costello R; Sainty D; Lafage-Pochitaloff M; Gabert J
Leuk Lymphoma; 1997 Apr; 25(3-4):225-32. PubMed ID: 9168433
[TBL] [Abstract][Full Text] [Related]
38. Use of pulsed field gel electrophoresis to characterize BCR gene involvement in CML patients lacking M-BCR rearrangement.
Min GL; Martiat P; Pu GA; Goldman J
Leukemia; 1990 Sep; 4(9):650-6. PubMed ID: 2395384
[TBL] [Abstract][Full Text] [Related]
39. [Molecular analysis of chronic Philadelphia chromosome negative myeloid leukemia: study of 6 cases].
Cervantes F; Urbano-Ispizua A; Pujades A; Bosch F; Vives-Corrons JL; Montserrat E; Rozman C
Med Clin (Barc); 1992 Sep; 99(8):286-8. PubMed ID: 1453821
[TBL] [Abstract][Full Text] [Related]
40. Heterogeneous features of Ph-negative CML--possible existence of Ph-negative, bcr-rearrangement-negative CML.
Kato Y; Sawada H; Tashima M; Yumoto Y; Okuda T; Ueda T; Yamagishi M; Uchino H
Nihon Ketsueki Gakkai Zasshi; 1989 Sep; 52(6):1004-12. PubMed ID: 2588950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
